Home/Filings/4/0001193125-25-191463
4//SEC Filing

Munshi Amit 4

Accession 0001193125-25-191463

CIK 0001750149other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 7:48 PM ET

Size

6.1 KB

Accession

0001193125-25-191463

Insider Transaction Report

Form 4
Period: 2025-02-21
Munshi Amit
Director
Transactions
  • Award

    Common Stock

    2025-02-21+57,26557,265 total
Holdings
  • Common Stock

    (indirect: By Trust)
    365,000
Footnotes (1)
  • [F1]Represents shares of common stock issued to the Reporting Person as merger consideration upon the completion of the acquisition of CorHepta Pharmaceuticals, Inc. ("CorHepta") on February 21, 2025 (the "Closing Date") by the Issuer, pursuant to the Agreement and Plan of Merger and Reorganization by and among the Issuer, Project IKT Merger Sub, Inc., CorHepta, and Preston S. Klassen, solely in his capacity as sellers' representative. Of these, 9,544 shares vested on the Closing Date, 28,632 shares shall vest on the first anniversary of the Closing Date. 25% of the remaining 19,089 shares will vest upon achievement of a certain milestone and 75% will vest on the first anniversary of the Closing Date, subject to the Reporting Person's continued service through such date; provided that, if the milestone is not achieved by the first anniversary of the Closing Date, all 19,089 shares shall be forfeited.

Documents

1 file

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1
  • filerCIK 0001612551

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 7:48 PM ET
Size
6.1 KB